Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulin.
Panelo
Araceli
A
Department of Medicine, Amang Rodriguez Medical Centre, Marikina City 1800, Philippines. aapanelo@yahoo.com
Wing
Jeffrey Robert
JR
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D002219:Carbamates / Q000008:administration & dosage / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007336:Insulin, Isophane / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010352:Patient Dropouts; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*
D001786:Blood Glucose; D002219:Carbamates; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007336:Insulin, Isophane; D010880:Piperidines; C072379:repaglinide